145 related articles for article (PubMed ID: 10374333)
41. Immunohistochemical analysis of 36 cases of chondroblastomas: A single institutional experience.
Rekhi B; Ghate S; Shah A; Ramadwar M; Gulia A
Ann Diagn Pathol; 2020 Feb; 44():151440. PubMed ID: 31862519
[TBL] [Abstract][Full Text] [Related]
42. COPS3 amplification and clinical outcome in osteosarcoma.
Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
[TBL] [Abstract][Full Text] [Related]
43. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
[TBL] [Abstract][Full Text] [Related]
44. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044
[TBL] [Abstract][Full Text] [Related]
45. Association of FGFR3 and MDM2 gene nucleotide polymorphisms with bone tumors.
Naumov VA; Generozov EV; Solovyov YN; Aliev MD; Kushlinsky NE
Bull Exp Biol Med; 2012 Oct; 153(6):869-73. PubMed ID: 23113306
[TBL] [Abstract][Full Text] [Related]
46. Differential expression of VEGF isoforms and VEGF receptors in cartilaginous tumors.
Yukata K; Matsui Y; Goto T; Kubo T; Yasui N
Anticancer Res; 2005; 25(2A):955-7. PubMed ID: 15868933
[TBL] [Abstract][Full Text] [Related]
47. [Studies on MDM2 oncogene expression and its effect on pancreatic carcinoma cells].
Guo H; Liu T; Gao J
Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):232-5. PubMed ID: 9275659
[TBL] [Abstract][Full Text] [Related]
48. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
[TBL] [Abstract][Full Text] [Related]
49. The MDM2 gene amplification database.
Momand J; Jung D; Wilczynski S; Niland J
Nucleic Acids Res; 1998 Aug; 26(15):3453-9. PubMed ID: 9671804
[TBL] [Abstract][Full Text] [Related]
50. [Mdm2, p53 and the cell cycle: when well enough is best left alone].
Maréchal V
Pathol Biol (Paris); 1997 Dec; 45(10):824-32. PubMed ID: 9769946
[TBL] [Abstract][Full Text] [Related]
51. Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas.
Wunder JS; Eppert K; Burrow SR; Gokgoz N; Bell RS; Andrulis IL
Oncogene; 1999 Jan; 18(3):783-8. PubMed ID: 9989829
[TBL] [Abstract][Full Text] [Related]
52. Frequency of Mouse Double Minute 2 (MDM2) and Mouse Double Minute 4 (MDM4) amplification in parosteal and conventional osteosarcoma subtypes.
Duhamel LA; Ye H; Halai D; Idowu BD; Presneau N; Tirabosco R; Flanagan AM
Histopathology; 2012 Jan; 60(2):357-9. PubMed ID: 22074548
[No Abstract] [Full Text] [Related]
53. Strong correlation of basement membrane degradation with p53 inactivation and/or MDM2 overexpression in superficial urothelial carcinomas.
Ozdemir E; Kakehi Y; Okuno H; Habuchi T; Okada Y; Yoshida O
J Urol; 1997 Jul; 158(1):206-11. PubMed ID: 9186361
[TBL] [Abstract][Full Text] [Related]
54. p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1.
Giannikaki E; Kouvidou C; Tzardi M; Stefanaki K; Koutsoubi K; Gregoriou M; Zois E; Kakolyris S; Mavroudi C; Delides G; Georgoulias V; Kanavaros P
Anticancer Res; 1997; 17(3C):2123-7. PubMed ID: 9216675
[TBL] [Abstract][Full Text] [Related]
55. Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma.
Venneker S; Szuhai K; Hogendoorn PCW; Bovée JVMG
Virchows Arch; 2020 Jan; 476(1):135-146. PubMed ID: 31728625
[TBL] [Abstract][Full Text] [Related]
56. Detection of c-fos expression in benign and malignant musculoskeletal lesions.
Weisstein JS; Majeska RJ; Klein MJ; Einhorn TA
J Orthop Res; 2001 May; 19(3):339-45. PubMed ID: 11398843
[TBL] [Abstract][Full Text] [Related]
57. Cellular expression of MDM2 and p53 in childhood leukemias with poor prognosis.
Gustafsson B; Christenson B; Hjalmar V; Winiarski J
Med Pediatr Oncol; 2000 Feb; 34(2):117-24. PubMed ID: 10657873
[TBL] [Abstract][Full Text] [Related]
58. p63 expression in giant cell-containing lesions of bone and soft tissue.
de la Roza G
Arch Pathol Lab Med; 2011 Jun; 135(6):776-9. PubMed ID: 21631272
[TBL] [Abstract][Full Text] [Related]
59. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.
Schaefer IM; Fletcher JA; Nielsen GP; Shih AR; Ferrone ML; Hornick JL; Qian X
Cancer Cytopathol; 2018 Aug; 126(8):552-566. PubMed ID: 29757500
[TBL] [Abstract][Full Text] [Related]
60. The metastatic behavior of osteosarcoma by gene expression and cytogenetic analyses.
Salinas-Souza C; De Oliveira R; Alves MT; Garcia Filho RJ; Petrilli AS; Toledo SR
Hum Pathol; 2013 Oct; 44(10):2188-98. PubMed ID: 23845465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
